Showing results (381-390 of 433) with videos related to

Sort By:
Pageof 44
Nature|November 3, 2009
Predicting new molecular targets for known drugsMichael J Keiser, Vincent Setola, John J Irwin, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 26, 2011
Discovery of β-arrestin-biased dopamine D2 ligands for probing signal transduction pathways essential for antipsychotic efficacyJohn A Allen, Julianne M Yost, Vincent Setola, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 11, 2013
A Gαs DREADD mouse for selective modulation of cAMP production in striatopallidal neuronsMartilias S Farrell, Ying Pei, Yehong Wan, et al.
Nature|February 11, 2020
Virtual discovery of melatonin receptor ligands to modulate circadian rhythmsReed M Stein, Hye Jin Kang, John D McCorvy, et al.
Nature Communications|December 6, 2023
Docking for EP4R antagonists active against inflammatory painStefan Gahbauer, Chelsea DeLeon, Joao M Braz, et al.
JACC. Basic to Translational Science|December 14, 2023
Development of a Peripherally Restricted 5-HT2B Partial Agonist for Treatment of Pulmonary Arterial HypertensionMichael S Valentine, Aaron M Bender, Sheila Shay, et al.
Science (New York, N.Y.)|July 25, 2020
The activities of drug inactive ingredients on biological targetsJoshua Pottel, Duncan Armstrong, Ling Zou, et al.
Biorxiv : the Preprint Server for Biology|January 8, 2024
AlphaFold2 structures template ligand discoveryJiankun Lyu, Nicholas Kapolka, Ryan Gumpper, et al.
Cell|February 11, 2021
Structural insights into the human D1 and D2 dopamine receptor signaling complexesYouwen Zhuang, Peiyu Xu, Chunyou Mao, et al.
Nature|November 10, 2015
Allosteric ligands for the pharmacologically dark receptors GPR68 and GPR65Xi-Ping Huang, Joel Karpiak, Wesley K Kroeze, et al.
Pageof 44